首页> 外国专利> MULTIPLE BIOMARKER SETS FOR BREAST CANCER DIAGNOSIS, DETECTION METHOD THEREFOR, AND BREAST CANCER DIAGNOSTIC KIT COMPRISING ANTIBODY AGAINST SAME

MULTIPLE BIOMARKER SETS FOR BREAST CANCER DIAGNOSIS, DETECTION METHOD THEREFOR, AND BREAST CANCER DIAGNOSTIC KIT COMPRISING ANTIBODY AGAINST SAME

机译:用于乳腺癌诊断的多种生物标记物集,其检测方法以及包括针对同一抗体的乳腺癌诊断试剂盒

摘要

The present invention relates to a biomarker set for the diagnosis of breast cancer, comprising two or more protein markers from among apolipoprotein C1, apolipoprotein (a), neural cell adhesion molecule L1-like protein, carbonate dehydratase 1, and fibronectin, to a method for detecting the biomarker set in a blood sample using a multiple reaction monitoring method, to a breast cancer diagnostic kit comprising an antibody specific to the protein of the biomarker set, and to a method for detecting the protein of the marker set in blood using an antigen-antibody binding reaction. The method for detecting a protein marker set for the diagnosis of breast cancer in a blood sample using an MRM method or an antigen-antibody binding reaction and the diagnostic kit for breast cancer according to the present invention not only exhibit excellent diagnostic sensitivity and accuracy as compared to diagnostic methods using a single marker, but also enable the diagnosis of breast cancer in a significantly simple manner using the blood of a patient, and therefore can be effectively used in the early diagnosis of breast cancer.
机译:本发明涉及一种用于诊断乳腺癌的生物标志物,其包括载脂蛋白C1,载脂蛋白(a),神经细胞粘附分子L1样蛋白,碳酸盐脱水酶1和纤连蛋白中的两种或更多种蛋白标志物。用于通过多重反应监测方法检测血样中生物标志物组的方法,针对包含该生物标志物组蛋白特异性抗体的乳腺癌诊断试剂盒的方法以及使用免疫印迹法检测血液中标志物组蛋白的方法的方法抗原-抗体结合反应。根据本发明的使用MRM方法或抗原-抗体结合反应检测用于诊断血液样品中的乳腺癌的蛋白质标志物组的方法和用于乳腺癌的诊断试剂盒不仅显示出优异的诊断敏感性和准确性,而且与使用单一标记物的诊断方法相比,还可以使用患者的血液以非常简单的方式诊断乳腺癌,因此可以有效地用于乳腺癌的早期诊断。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号